United States · FDA National Drug Code directory

ZEMAIRA

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 57516-101_31a53b86-857c-a2d9-e063-6394a90abfb8
Product NDC: 57516-101
Form: KIT
Composition / generic term: alpha-1-proteinase inhibitor human kit
Labeler: Fisher Clinical Services Inc.
Marketing category: BLA
Marketing start / end (source format): 20220222
Source listing expiry: 20261231

Source-listed ingredients

Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.

These values do not establish equivalence or a dose recommendation.

Packages

1 KIT in 1 CARTON (57516-101-02) * 20 mL in 1 VIAL, SINGLE-DOSE (57516-102-01) * 20 mL in 1 VIAL, SINGLE-DOSE (57516-103-20) · 57516-101-02

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →